Coherus BioSciences Inc. (NASDAQ:CHRS) Reports Product Revenue Of $113.6 Million In...

Max - 0

Nektar Therapeutics (NASDAQ:NKTR) Reports Q3 2020 Financial Results And Bempegaldesleukin Development...

Max - 0

G1 Therapeutics Inc. (NASDAQ:GTHX) Revises Its 2020 Guidance And Announces Q3...

Max - 0

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) Announces Its Q3 2020 Financial Results And...

Max - 0

Molecular Templates Inc. (NASDAQ:MTEM) Reports Its Q3 Financial Results And Updates...

Max - 0

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) Releases Q3 2020 Results And Provides Corporate...

Max - 0

Arcus Biosciences Inc. (NASDAQ:RCUS) Releases Its Q3 2020 Financial Results And...

Max - 0

EyePoint Pharmaceutical Inc. (NASDAQ:EYPT) Reports Revenue Of $15.7 Million In Q3...

Max - 0

CymaBay Therapeutics Inc. (NASDAQ:CBAY) Announce Its Q3 2020 Results And Progress...

Max - 0

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Reports Q3 2020 Financial Results Boosted By...

Max - 0
1...162163164...248Page 163 of 248